Email Newsletters

Bioscience

Cheshire drug maker’s 2Q profits soar

Cheshire-based Alexion Pharmaceuticals Inc. today posted higher quarterly earnings, helped by a 55 percent jump in worldwide...

Pfizer’s 2Q profit plunges 19 percent

Drug giant Pfizer Inc., which has research and development operations in Groton and New London, said today...

GE teams up to market stem cell products

Fairfield-based General Electric Co.'s GE Healthcare unit and Geron Corp. said today they agreed to develop and...

Achillion begins anti-virus human trial

New Haven-based Achillion Pharmaceuticals Inc. announced today the start of human clinical trials in Europe of its...
ADVERTISEMENT

CuraGen expands test of breast cancer drug

Ailing Branford biotech firm CuraGen Corp. announced today the expansion of clinical trials on its treatment for...

Cheshire firm’s Soliris drug lauded

Leerink Swann analyst Howard Liang reaffirmed an "outperform" rating for Cheshire-based Alexion Pharmaceuticals Inc. today, citing the...

CuraGen agrees to $95M buyout

Celldex Therapeutics Inc., based in Needham, Mass., said it agreed to acquire New Haven-based CuraGen Corp. for...

CT firm involved in pain-therapy trial

A Fairfield company's pain-therapy machine will undergo clinical testing on patients at a Virginia cancer clinic. ...
ADVERTISEMENT

Pfizer in deals to expand generic, other sales

Pfizer Inc., which has research and development operations in Connecticut, has broadened its partnership with an Indian...

Achillion, partner divided on drug

New Haven-based Achillion Pharmaceuticals Inc. and its partner Gilead Sciences Inc. are at odds over future development...
ADVERTISEMENT

Latest Stories

More Business News

Movers & Shakers

More Movers & Shakers | Submit an Announcement
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

Inside Sales Specialist

Connecticut Trailers, Inc
,
Bolton CT
55,000-75,000
More Jobs | Submit a Job
More Events | Submit an Event